BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 17181481)

  • 1. Immunoprevention of cancer: time to reconsider timing of vaccination against cancer.
    Spisek R
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1689-91. PubMed ID: 17181481
    [No Abstract]   [Full Text] [Related]  

  • 2. Searching of optimal vaccination schedules: application of genetic algorithms to approach the problem in cancer immunoprevention.
    Pennisi MA; Pappalardo F; Zhang P; Motta S
    IEEE Eng Med Biol Mag; 2009; 28(4):67-72. PubMed ID: 19622427
    [No Abstract]   [Full Text] [Related]  

  • 3. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of tumor immunity, immunotherapy and cancer vaccines.
    Ostrand-Rosenberg S
    Curr Opin Immunol; 2004 Apr; 16(2):143-50. PubMed ID: 15023405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal tumor antigens for cancer vaccination: targeting telomerase for immunoprevention.
    Vonderheide RH
    Discov Med; 2007 Aug; 7(39):103-8. PubMed ID: 18093471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancer immunotherapy. A future therapeutical choice?].
    Bertolaccini L; Olivero G
    Minerva Chir; 2001 Apr; 56(2):183-91. PubMed ID: 11353352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DC-based cancer vaccines: lessons from clinical trials.
    Brody JD; Engleman EG
    Cytotherapy; 2004; 6(2):122-7. PubMed ID: 15203988
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccination for treatment and prevention of cancer in animal models.
    Cavallo F; Offringa R; van der Burg SH; Forni G; Melief CJ
    Adv Immunol; 2006; 90():175-213. PubMed ID: 16730264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches to immunoprevention and immunotherapy of neoplasms.
    Glushkov AN
    Russ J Immunol; 2002 Oct; 7(3):219-28. PubMed ID: 12674931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells in cancer immunotherapy.
    Vulink A; Radford KJ; Melief C; Hart DN
    Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization in tumor prevention.
    Forni G; Curcio C; Spadaro M; Iliffe J; Quaglino E; Di Carlo E; Musiani P; Lollini PL
    Int Immunopharmacol; 2003 Aug; 3(8):1151-8. PubMed ID: 12860170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of cancer.
    Oettgen HF
    N Engl J Med; 1977 Sep; 297(9):484-91. PubMed ID: 301988
    [No Abstract]   [Full Text] [Related]  

  • 14. The rationale for prophylactic cancer vaccines and need for a paradigm shift.
    Sobol RE
    Cancer Gene Ther; 2006 Aug; 13(8):725-31. PubMed ID: 16543919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promises and limitations of murine models in the development of anticancer T-cell vaccines.
    Lévy F; Colombetti S
    Int Rev Immunol; 2006; 25(5-6):269-95. PubMed ID: 17169777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccines: successes and limitations in cancer and infectious disease.
    Lowe DB; Shearer MH; Kennedy RC
    J Cell Biochem; 2006 May; 98(2):235-42. PubMed ID: 16440328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology of cancer gene therapy.
    Whartenby KA; Abboud CN; Marrogi AJ; Ramesh R; Freeman SM
    Lab Invest; 1995 Feb; 72(2):131-45. PubMed ID: 7853848
    [No Abstract]   [Full Text] [Related]  

  • 19. DC-based cancer vaccines.
    Gilboa E
    J Clin Invest; 2007 May; 117(5):1195-203. PubMed ID: 17476349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of vaccine's schedules using models.
    Pappalardo F; Motta S; Lollini PL; Mastriani E
    Cell Immunol; 2006 Dec; 244(2):137-40. PubMed ID: 17442286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.